Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achie...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-09-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC2741593?pdf=render |